Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 1883Carcinoma, Non-Small-Cell Lung 1345Prostatic Neoplasms 980Colorectal Neoplasms 848Multiple Myeloma 740Leukemia, Myeloid, Acute 725Neoplasms 689Lung Neoplasms 678Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 566Stomach Neoplasms 522Leukemia 511Recurrence 490Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 450Lymphoma, Non-Hodgkin 442Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 422Myelodysplastic Syndromes 416Squamous Cell Carcinoma of Head and Neck 415Head and Neck Neoplasms 402Brain Neoplasms 402Rectal Neoplasms 395Glioblastoma 374Carcinoma, Renal Cell 349Hodgkin Disease 338Lymphoma, Follicular 336

Interventions

padeliporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Localized Prostate Cancer × Clear all
NCT03315754 2024-12-20

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Steba Biotech S.A.

Phase 2 Active not recruiting
50 enrolled 8 charts
Genitourinary

Localized Prostate Cancer

NCT05010343 2021-11-15

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Shanghai Proton and Heavy Ion Center

Phase 2 Recruiting
140 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡